E-LIB Suche - Ergebnisse für: Iversen, P.

1

NfL and GFAP in serum are associated with microstructural b..:

Ammitzbøll, C. ; Dyrby, T.B. ; Börnsen, L....
Multiple Sclerosis and Related Disorders. 77 (2023) - p. 104854 , 2023

Link: https://doi.org/10.1016/..

2

Incidence and survival trends of de-novo metastatic prostat..:

Helgstrand, J.T. ; Røder, M. ; Klemann, N....
European Urology Supplements. 17 (2018) 2 - p. e383-e384 , 2018

Link: https://doi.org/10.1016/..

3

Risk of mortality after TUR-P in Denmark: Results from DaPC..:

Klemann, N. ; Helgstrand, T. ; Brasso, K....
European Urology Supplements. 17 (2018) 2 - p. e1048 , 2018

Link: https://doi.org/10.1016/..

4

P1564Coronary artery disease detected on cardiac computed t..:

Therkildsen, J ; Winther, S ; Jorgensen, H S...
European Heart Journal. 39 (2018) suppl_1 - p. , 2018

Link: https://doi.org/10.1093/..

5

Disability in progressive MS is associated with T2 lesion c..:

Ammitzbøll, C. ; Dyrby, T.B. ; Lyksborg, M....
Multiple Sclerosis and Related Disorders. 20 (2018) - p. 73-77 , 2018

Link: https://doi.org/10.1016/..

6

Radiographic progression with nonrising PSA in metastatic c..:

Bryce, A H ; Alumkal, J J ; Armstrong, A...
Prostate Cancer and Prostatic Diseases. 20 (2017) 2 - p. 221-227 , 2017

Link: https://doi.org/10.1038/..

7

Improved survival in patients diagnosed with metastatic pro..:

Helgstrand, J.T. ; Klemann, N. ; Toft, B....
European Urology Supplements. 16 (2017) 3 - p. e76-e77 , 2017

Link: https://doi.org/10.1016/..

8

Population-based analysis: Changes in the natural history o..:

Helgstrand, J.T. ; Klemann, N. ; Toft, B.G....
European Urology Supplements. 16 (2017) 3 - p. e1837-e1838 , 2017

Link: https://doi.org/10.1016/..

9

The CPC risk calculator app: A validated tool to predict re..:

Røder, M.A. ; Berg, K.D. ; Loft, M.D....
European Urology Supplements. 16 (2017) 3 - p. e1874-e1878 , 2017

Link: https://doi.org/10.1016/..

10

432 A novel model to estimate a patient's individual risk o..:

Røder, M.A. ; Berg, K.D. ; Thomsen, F.B....
European Urology Supplements. 15 (2016) 3 - p. e432 , 2016

Link: https://doi.org/10.1016/..

11

529 ERG protein expression is not an independent risk-facto..:

Berg, K.D. ; Røder, M.A. ; Thomsen, F.B....
European Urology Supplements. 14 (2015) 2 - p. e529 , 2015

Link: https://doi.org/10.1016/..

12

323 Associations between PSA kinetics and cause-specific mo..:

Thomsen, F.B. ; Brasso, K. ; Berg, K.D....
European Urology Supplements. 14 (2015) 2 - p. e323 , 2015

Link: https://doi.org/10.1016/..

13

427 Urokinase plasminogen activator receptor (uPAR) assessm..:

Lippert, S. ; Berg, K.D. ; Høyer-Hansen, G....
European Urology Supplements. 14 (2015) 2 - p. e427 , 2015

Link: https://doi.org/10.1016/..

14

LBA3 Enzalutamide in men with chemotherapy-naïve metastatic..:

Tombal, B. ; Iversen, P. ; Miller, K....
European Urology Supplements. 13 (2014) 1 - p. LBA3 , 2014

Link: https://doi.org/10.1016/..

15

345 ERG-expression is an independent predictor of disease p..:

Berg, K.D. ; Vainer, B. ; Thomsen, F.B....
European Urology Supplements. 13 (2014) 1 - p. e345 , 2014

Link: https://doi.org/10.1016/..